Thrombocytopenia
Research from Harvard University reveals new findings on thrombocytopenia
Published in Hospital Law Weekly, February 5th, 2009
Data detailed in 'Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes' have been presented. According to recent research from the United States, "Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction that occurs following exposure to unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH). HIT with thrombosis (HITT) can cause devastating venous thromboembolism or arterial clots, prolonged hospitalization, and increased costs."
"To explore the economic and clinical implications of HIT and HITT, we initiated a single-center patient registry. In this report, we describe patient characteristics, comorbidities,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2009-02-05)
More Articles from Hospital Law Weekly
- Diabetes Care
Studies conducted at D. Balabanova et al on diabetes care recently published - Health and Society
Research data from L.C. Steinhardt and colleagues update understanding of health and society - Health and Society
Studies from C. Izugbara and colleagues reveal new findings on health and society - Human Reproduction
Reports from S. Yee and colleagues advance knowledge in human reproduction - Life Sciences
New life sciences study findings recently were reported by researchers at University of Michigan - Life Sciences
Research on life sciences reported by scientists at St. James University - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
